Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
Denosumab is a commonly used antiresorptive treatment in patients with osteoporosis or solid tumours with bone metastases. Upon denosumab discontinuation, a rebound phenomenon can occur that results in an increased (vertebral) fracture risk. This phenomenon is well-known in the setting of osteoporos...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2022-06-01
|
| Col·lecció: | Bone Reports |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2352187222004168 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|